A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
AI-assisted Biomarker
It’s the use of machine learning and statistical AI models to identify biological features (or combinations of features) that correlate with disease state, prognosis, or treatment response. Why AI is needed (first principles) Modern datasets…
-
Multi-Omic Diagnostics
Multi-omic diagnostics integrate two or more “omics” layers to generate a single clinical insight. Common omics layers: Single-omic = snapshotMulti-omic = systems-level diagnosis Core mechanism Limitation Multi-omic advantage DNA mutation ≠ disease RNA/protein show functional…
-
RNA Editing vs RNA Regulation
1. RNA Editing (ADAR-based systems) RNA editing changes the sequence of an RNA molecule after it is transcribed—without altering DNA. Most therapeutic systems are based on ADAR (adenosine deaminase acting on RNA) enzymes. Core mechanism…
BioTech IP Review 